Stemline Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Stemline Therapeutics Inc inventory turnover ratio, the Stemline Therapeutics Inc's ability to sell and replace its inventory in the first quarter 2020, sequentially increased to 2.41 in the first quarter 2020, a new company high. Average inventory processing period, for the Stemline Therapeutics Inc in Mar 31 2020 quarter, has decreased to 151 days, compare to 159 days, in the Dec 31 2019 quarter.

Within Healthcare sector 228 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1588 in the fourth quarter 2019, to 1590.

STML Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Stemline Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

STML Inventory Turnover Ratio	(Mar 31 2020) I. Quarter	(Dec 31 2019) IV. Quarter	(Sep 30 2019) III. Quarter	(Jun 30 2019) II. Quarter	(Mar 31 2019) I. Quarter
Y / Y Inventory Growth	63.72 %	-	-	-	-
Y / Y Cost of Sales Growth	647.7 %	-	-	16.63 %	-
Inventory Turnover Ratio (TTM)	2.41	2.3	0.95	0.59	2.76
STML's Total Ranking	# 1590	# 1588	# 0	# 1593	# 1588
Average inventory processing period	152	159	386	614	132
Seq. Inventory Growth	20.65 %	-59.7 %	-21.84 %	330.77 %	-
Seq. Cost of Sales Growth	-79.67 %	194.19 %	83.77 %	580.24 %	-

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 69
Healthcare Sector	# 229
Overall Market	# 1590

Inventory Turnover Ratio Statistics
High	Average	Low
2.41	2.35	2.3
(Mar 31 2020)		(Dec 31 2019)

STML Company Profile >> Back to STML Efficiency Comparisons >> Compare STML Inventory Turnover Ratio to its Competitors

Financial Statements
Stemline Therapeutics Inc's Inventories	$ 1 Millions	Visit STML's Balance sheet
Stemline Therapeutics Inc's Cost of Revenues TTM	$ 5 Millions	Visit STML's Income Statement
What are STML's Sales?		Visit STML's Sales by Segment

Other Inventory Turnover Ratios
Stemline Therapeutics Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
STML's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for STML's Competitors
Inventory Turnover Ratio for STML's Suppliers
Inventory Turnover Ratio for STML's Customers

You may also want to know
STML's Sales Growth Rates	STML's Pe Price to earnings ratio	STML's Receivables Turnover Ratio	STML's Stock Quote
STML's Net Income Growth Rates	STML's Ps Price to Sales ratio	STML's Sales per Employee	STML's Asset Turnover Ratio
STML's Net Margin	STML's Pb Price to Book ratio	STML's Financial Strength Ratios	STML's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2020, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2020	Inventories at quarter ending Mar 31 2020
Scienture Holdings Inc	10.67	$ 2.763 Millions	$ 0 Millions
Musclepharm Corporation	10.52	$ 66.546 Millions	$ 6 Millions
Opko Health Inc	9.58	$ 504.190 Millions	$ 53 Millions
Caredx Inc	9.56	$ 57.847 Millions	$ 6 Millions
Cryo cell International Inc	9.45	$ 10.073 Millions	$ 1 Millions
Charles River Laboratories International inc	9.30	$ 1,427.723 Millions	$ 154 Millions
Steris Plc	9.27	$ 1,710.972 Millions	$ 185 Millions
Orgenesis Inc	9.00	$ 14.058 Millions	$ 2 Millions
Perspective Therapeutics Inc	8.21	$ 4.393 Millions	$ 1 Millions
Kewaunee Scientific Corporation	8.05	$ 124.113 Millions	$ 15 Millions
Bionexus Gene Lab Corp	8.02	$ 0.065 Millions	$ 0 Millions
Align Technology inc	8.02	$ 819.506 Millions	$ 102 Millions
Advanced Container Technologies Inc	7.98	$ 1.034 Millions	$ 0 Millions
Ufp Technologies Inc	7.56	$ 145.045 Millions	$ 19 Millions
Catalent Inc	7.46	$ 1,967.200 Millions	$ 264 Millions
Enzo Biochem Inc	7.13	$ 55.149 Millions	$ 8 Millions
Fonar Corporation	6.97	$ 12.395 Millions	$ 2 Millions
Viemed Healthcare Inc	6.86	$ 13.939 Millions	$ 2 Millions
Omnova Solutions Inc	6.75	$ 548.400 Millions	$ 81 Millions
Sunshine Biopharma Inc	6.66	$ 0.109 Millions	$ 0 Millions
Nexgel Inc	6.61	$ 0.790 Millions	$ 0 Millions
Twist Bioscience Corporation	6.60	$ 51.136 Millions	$ 8 Millions
Carlisle Companies Incorporated	6.54	$ 3,408.400 Millions	$ 521 Millions
Horizon Therapeutics Public Limited Company	6.42	$ 371.449 Millions	$ 58 Millions
Dmk Pharmaceuticals Corporation	6.21	$ 15.540 Millions	$ 3 Millions
Avid Bioservices Inc	6.15	$ 55.770 Millions	$ 9 Millions
Genmark Diagnostics Inc	6.07	$ 66.338 Millions	$ 11 Millions
Vericel Corporation	6.05	$ 38.853 Millions	$ 6 Millions
Htg Molecular Diagnostics Inc	5.99	$ 7.881 Millions	$ 1 Millions
Lantheus Holdings Inc	5.94	$ 182.802 Millions	$ 31 Millions

Date modified: 2026-08-29T17:26:40+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.